Osteopontin (OPN), an extracellular matrix (ECM) glyco-phosphoprotein, plays an important role in autoimmune-mediated demyelinating diseases, including multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). As an integrin and CD44 binding protein it participates in bidirectional communication between the ECM and target cells and affects transduction pathways that maintain neuronal and immune cells homeostasis. Its biological activity is also heavily influenced by microenvironment, which stimulates the cleavage of OPN and changes its functions.
Introduction
Osteopontin (OPN), known also as secreted phosphoprotein 1 and early T lymphocyte activation 1 (ETA-1) is an extracellular matrix (ECM) protein, which belongs to a family of small integrin-binding ligand N-linked glycoproteins (SIBLINGs). It was first described by Senger and coauthors as a 60 kDa phosphoprotein, secreted from transformed mammalian cells (Senger et al., 1979) . Lately, it was identified in osteoblasts and bone calcified matrix, but today it is known that OPN acts as a pleiotropic cytokine, which in various cells affects multiple physiological and pathological processes (Ashkar et al., 2000; Fisher et al., 2001; Bellachene, 2008 ).
Current knowledge also shows that functional properties of SIBLINGs depend on functions of extracellular proteases and cellular uptake of ECM proteins or their proteolysed fragments, as well as on processes that regulate their trafficking into the secretory and the endo/lysosomal degradation pathways inside the cells (Bellachene, 2008; Hellewell and Adams, 2015) .
Importantly, some ECM components after proteolysis may exhibit differential biological activities owing to the removal of functional domains or exposure of cryptic binding sites (Fedarko et al., 2004) .
In this context it is known that full length OPN contains an arginine-glycine-aspartate (RGD) motif at NH2-terminal fragment and a protease-hypersensitive cleavage site that separates the integrin-binding site from the C-terminal fragments of OPN containing CD44 binding domains (reviewed by (Okamoto, 2007; Scatena et al., 2007) .The RGD sequence, which is 100% conserved between species, acts as a major binding site for αv/β3, αv/β1, α5/β1, α8/β1, and αv/β5 integrins (Ashkar et al., 2000; Denhardt et al., 2001) . Cleavage by thrombin at Arg168-Ser169 exposes a serine-valine valine-tyrosine-glutamate-leucinearginine (SVVYGLR) domain (human) or SLAYGLR domain (mouse and rat). It is cryptic in intact OPN, but after cleavage with thrombin it binds α9/β1 and α4/β1 integrins that are the main adhesion molecules involved in lymphocyte transmigration to the brain (Smith et al., 1996; Yokosaki et al., 1999; Green et al., 2001; Boggio et al., 2016) . Importantly, additional cleavage of OPN within the SVVYGLR site may be induced by several MMPs, including MMP2, MMP3, MMP7, MMP9, and MMP12 (Agnihotri et al., 2001; Gao et al., 2004; Hou, 2004; Goncalves DaSilva et al., 2010) . These new MMP-cleaved OPN fragments may exhibit reduced ability to bind α4/α9 integrins (Yokosaki et al., 2005) , but also the greater adhesive and migratory activities than full-length OPN (Gao et al., 2004) .
Through sequences in C-terminal fragment OPN interacts also with CD44v3-v6 splice variants in an RGD independent manner (Weber et al., 1999) and participates in immune regulation (Guan et al., 2011) and in tumorigenesis (Teramoto et al., 2004) . Besides, OPN molecule contains heparin binding, hydroxyapatitite and calcium binding regions and domains responsible for transglutamination, as well as multiple Ser and Thr phosphorylation sites and sites for N-and O-linked glycosylation (Okamoto, 2007; Scatena et al., 2007) . Furthermore, along to its classically secreted form (s-OPN) OPN also exists in an intracellular form (i-OPN) (Shinohara et al., 2008a; Cantor and Shinohara, 2009; Hellewell and Adams, 2015; Rittling and Singh, 2015) . It may be generated from the same mRNA as s-OPN by alternative translation of a non-AUG site downstream of the canonical AUG sequence and accompanied by deletion of the N-terminal 16-aa signal sequence that targets nascent protein to secretory vesicles (Shinohara et al., 2008b) . Reports show that this form of OPN is a critical regulator for Toll like receptor-9 (TLR-9), TLR-7-dependent interferon-alpha (IFN-alpha) expression by plasmacytoid dendritic cells (DCs) and TH17 development (Shinohara et al., 2008a; Cantor and Shinohara, 2009; Morimoto et al., 2010; Inoue and Shinohara, 2011; Hellewell and Adams, 2015) .
Collectively, these data emphasize that pleiotropic functions of OPN depend on discrete changes in domains, on generation of its active cleaved products and on processes of posttranslational modifications, such as phosphorylation, glycosylation and sulphation that may generate different functional forms of OPN.
As a multi-faceted molecule OPN plays an important role also in neurodegenerative diseases, such as Parkinson's and Alzheimer's disease, as well as in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE) (Steinman, 2009; Braitch and Constantinescu, 2010; Carecchio and Comi, 2011; Niino and Kikuchi, 2011) . In these conditions OPN is mainly considered an inflammatory molecule, but since in some contexts OPN may function as a neuroprotectant, its ambiguous and "double-edged" sword activities have been often emphasized (Carecchio and Comi, 2011) .
The detrimental role of OPN in MS and EAE was first reported by Chabas and colleagues (2001) who showed that OPN transcript was abundant in plaques dissected from brains of patients with MS and within SC tissue of rats paralyzed by EAE, as well as that OPN -/-mice were resistant to progressive EAE. They also found that myelin-reactive T cells in OPN-/-mice produced more interleukin 10 (IL-10) and less interferon-γ than in OPN+/+ mice, proposing that OPN might regulate T helper cell-1 (TH1)-mediated autoimmune diseases (Chabas et al., 2001) . The data were confirmed by findings that OPN deficient mice had attenuated EAE and decreased inflammatory infiltration and demyelination in the spinal cords (Jansson et al., 2002) , by data showing that treatment of EAE mice with recombinant (r) OPN might exacerbate the disease in OPN deficient mice and trigger neurological relapse by inhibiting apoptosis of autoreactive immune cells (Hur et al., 2007) , as well as by findings that anti-OPN treatment might reduce clinical severity of EAE and IL-17 production (Murugaiyan et al., 2008) .
It should be also emphasized that the expression profile of OPN and its receptors show, timeand cell-dependent patterns (Kang et al., 2008) , as well as that OPN functions strictly depend on microenvironment in which thrombin (Boggio et al., 2016) , or different MMPs (Agnihotri et al., 2001; Gao et al., 2004; Hou, 2004; Goncalves DaSilva et al., 2010) contribute to proteolytic cleavage of OPN and generation of OPN fragments with distinct functions.
In this context, it has been shown that the RGD-binding domain of OPN might also enhance the survival of tyrosine hydroxylase (TH)-positive cells in rat substantia nigra against toxic insults (Iczkiewicz et al., 2010) , as well as that OPN in distinct conditions might have not only detrimental, but also a protective properties (Braitch and Constantinescu, 2010; Carecchio and Comi, 2011; Brown, 2012) , participating in processes of remyelination (Zhao et al., 2008) , in regeneration of peripheral motor axons (Wright et al., 2014) , hippocampal neurons (Plantman, 2012) and nigral cells (Iczkiewicz et al., 2006) .
In the present study, we examined the possibility that in the remodeling processes that take part in EAE OPN co-operates with metallothioneins (MTs), since this family of phylogenetically highly conserved proteins generally provide cytoprotective action against oxidative injury, DNA damage and apoptosis (Miles et al., 2000; Coyle et al., 2002) . As metal-binding and cysteine-rich proteins they participate in maintenance of Zn and Cu homeostasis, in protection against cytotoxicity of toxic metals, as well as in regulation of basic cellular processes, such as gene expression, apoptosis, proliferation, and differentiation.
Furthermore, acting through thiol groups, MTs ensure the protection against various types of injuries resulting from reactive oxygen (ROS) or nitrogen species (RNS), providing antiinflammatory and immunoregulatory functions (Andrews, 2000; Mocchegiani et al., 2000; Rink and Haase, 2007; Inoue et al., 2009; Isani and Carpene, 2014; Ling et al., 2016) . Importantly, it is generally accepted that MTs isoforms MT-I+II, have marked neuroprotective capacities (Penkowa, 2006; Pedersen et al., 2009; Manso et al., 2011) , and an impressive regulatory effect in demyelinating and inflammatory disease, such as MS and EAE .
Experimental Procedures

Experimental Animals
Experiments were performed on male Dark Agouti (DA) rats, aged 2-3 months. 
EAE Induction and Evaluation
Induction of chronic relapsing (CR)-EAE was performed in male DA rats by bovine brain white matter homogenate emulsion (BBH) in the complete Freund's adjuvant (CFA) (Sigma, St. Louis, Mo., USA), as previously described (Jakovac et al., 2011) . To each animal 2 x 0.1 mL emulsion was injected subcutaneously in each hind footpad. Control group was injected with the same dose of CFA. The evaluation of the clinical course was assessed daily using the following criteria: 0 -no symptoms; 1 -flaccid paralysis of tail; 2 -hind legs paresis; 3 -hind legs paralysis with incontinence and 4 -death of the animal.
Tissue preparation for paraffin slices
Animals with clinical score 3 (hind legs paralysis with incontinence) were sacrificed by exsanguination on day 13 or 14 after immunization. The exsanguination was done in deep anesthesia, induced by combination of Ketamine (80 mg/kg) and Xylasine (5 mg/kg), given by intraperitoneal (i. p.) injection, according to the guidance of European Community Council Directive (86/609/EEC) and recommendation of National Centre for the Replacement, Refinement and Reduction of Animals in Research ( www.nc3rs.org.uk ). The tissue samples of the lumbar spinal cord and the brain were rapidly removed from nine rats and fixed in 4 % buffered paraformaldehyde (Sigma, Germany) solution during 24 hours. Tissue was then embedded in paraffin wax and sections were cut at 4 µm using HM 340E microtome (Microtom, Germany). Heat induced epitope retrieval was done prior to staining procedure by heating tissue slides in boiled citrate buffer pH 6.0 four times, each 5 minutes, using a microwave steamer.
Immunohistochemistry
Immunohistochemical labeling of MT I+II proteins was performed on paraffin embedded tissues using DAKO EnVision+System, Peroxidase (DAB) kit according to the manufacturer's instructions (DAKO Cytomation, USA), as previously described (Jakovac et al., 2011) . Briefly, after washing and blocking non-specific binding and endogenous peroxidase activity mouse monoclonal anti-MT I+II IgG 1 antibody (clone E9; Dako Cytomation, USA; 1:50 with 1% BSA in PBS) were added to tissue samples and incubated overnight at 4ºC in a humid environment, followed by 45 min incubation with peroxidase labeled polymer conjugated to goat anti-mouse immunoglobulins containing carrier protein linked to Fc fragments to prevent nonspecific binding. The immunoreaction product was visualized by adding substrate-chromogen (DAB) solution.
For immunohistochemical analysis of OPN expression deparaffinized tissue sections were incubated with 1% BSA in PBS for one hour at room temperature to block non-specific binding. Immediately afterwards, incubation with goat polyclonal anti-OPN IgG antibody, which recognizes all OPN isoforms (R&D, USA, 1:200 with 1% BSA in PBS) was performed overnight at 4ºC in a humid environment. After washing, tissues were incubated with secondary HRP horse anti-goat IgG antibodies (Vector Laboratories, USA, 1:400 with 1% BSA in PBS) for one hour at room temperature in a humid environment. Immunoreactivity was visualized using DAB solution.
All tissues were counterstained with hematoxylin, dehydrated through gradient of ethanol, mounted using Entelan (Sigma-Aldrich, Germany) and examined with Olympus BX51 microscope (Olympus, Tokyo, Japan). The specificity of staining was confirmed by negative controls. For OPN-immunostaining, tissue samples were treated with an identical procedure under the same conditions, but with the omission of polyclonal primary antibodies. For MT-I+II-immunostaining, tissue samples were incubated with isotype-matched irrelevant antibodies (mouse IgG1 immunoglobulin, clone DAK-G01; Dako Cytomation, USA).
Immunofluorescence
Immunofluorescence labeling was also performed on paraffin embedded tissue sections. Images were captured on Olympus imaging system BX51 equipped with DP71CCD camera (Olympus, Tokyo, Japan) and CellF imaging software was used.
Western Blot Analyses
Spinal cords were collected from rats treated with BBH+CFA (N=3), with CFA (N=3) and from untreated (N=3) rats. Samples were snap-frozen in liquid nitrogen for protein isolation and stored at -80° C. Tissue was transferred in hypotonic buffer consisting of 10 mM HEPES (pH 7.9), 1.5 mM magnesium chloride, 10 mM potassium chloride, 10 mM 2-mercaptoethanol and protease inhibitor cocktail (Complete, Mini, EDTA-free tablets, Roche, Germany) as well as 1 mM phenylmethylsulfonyl fluoride (PMSF; Serva, Germany) and homogenized three times for 15 seconds with tissue homogenizer (Biospec, USA). The samples were left on ice for 15 minutes before adding Nonidet P40 (Roche, Germany) to a final concentration of 0.5% and then centrifuged at 3,000 rpm for 1 minute at 4°C. The resulting supernatants were centrifuged at 14,000 rpm for 30 seconds at 4°C. Obtained supernatants with cytoplasmic proteins were used for further procedure (Huber et al., 2007) .
Proteins were separated by 10% (OPN) and 13,5% (MT-I+II) sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), under reducing (OPN) and non-reducing (MT-I+II) conditions and then transferred onto a nitrocellulose membrane (BioRad, USA).
Membranes were blocked with 5% BSA (Sigma, Germany) in trisbuffered saline with 0.05% Tween-20 (TBST) and incubated with goat anti-OPN IgG antibody (R&D systems, USA; 1:500) and mouse anti-MT-I+II IgG 1 antibody (clone E9; Dako Cytomation, USA; 1:200), followed by incubation with species specific HRP-conjugated secondary antibodies. The rabbit anti-β-tubulin (Abcam, UK, 1:25 000) was used as a control of cytoplasmic proteins.
The mouse anti-β-actin (Milipore, USA, 1:80 000) was used as a control of protein loading.
For detection membranes were, incubated with Amersham ECL Prime (GE Healthcare, Sweden), and scanned with Kodak Image Station 440CF (Kodak, USA). The intensity of the bands was quantified using ImageJ software ( http://rsb.info.nih.gov/ij/ ). To determine the relative expression of analyzed proteins in spinal cord of immunized animals and animals treated only with CFA, the band density of each sample was compared with the band intensity obtained from spinal cord of untreated animals after normalization to an internal control β-actin.
RNA Extraction, Reverse Transcription and Real-Time PCR Analysis
Spinal cords were collected from rats treated with BBH+CFA (N=4), with CFA (N=4) and from untreated (N=4) rats. Samples were snap-frozen in liquid nitrogen for RNA isolation and stored at -80° C. Total RNA was extracted from frozen tissues, using Trizol Reagent (Invitrogen, USA), according to the protocol provided by the manufacturer (1 ml of Trizol per 100 mg of tissue). RNA was assayed by ultraviolet spectrophotometric measurements at a wavelength of 260 nm, and its purity was estimated by the ratio of A260/A280. Total RNA (5 µg) was treated with turbo DNA-free reagent (Ambion; Applied Biosystems, USA) to remove possible contamination with genomic DNA, followed by reverse transcription (High Capacity cDNA Reverse Transcription Kit; Applied Biosystems, USA), according to the manufacturer's instructions. Relative expression levels of OPN and MT-1 mRNA were determined by real-time PCR analysis using SYBR Green PCR Universal Mastermix (Applied Biosystems, USA) according to manufacturer's instructions. Oligonucleotide primers for rat OPN (forward 5'-ACAGTATCCCGATGCCACAG -3'; reverse 5'-GACTCATGGCTGGTCTTCCC -3'), rat MT-1 (forward 5'-CACCGTTGCTCCAGATTCAC -3'; reverse 5'-GCAGCAGCACTGTTCGTCAC -3') previously published (Banni et al., 2010.) and rat β-actin (forward 5'-CCACCAGTTCGCCATGGAT -3'; reverse 5'-CCATACCCACCATCACACCC -3') were obtained from Metabion (Planegg, Germany). ABI Prism 7300 Sequence Detector System (Applied Biosystems, USA) was used to perform quantitative PCR. Relative mRNA levels were determined after normalization to β-actin.
Statistical Analysis
The statistical analyses were performed using Statistica software version 12 (StatSoft Inc., Tulsa, OK, USA). The distribution of data was tested for normality using the KolmogorovSmirnov test. Differences between groups were assessed with either one-way analysis of variance (ANOVA) followed by the post hoc Scheffé test or by Kruskall-Wallis and MannWhitney U test. Statistical differences with p<0.05 were considered significant.
Results
EAE was induced in genetically susceptible DA rats, which react on immunization with BBH in CFA by development of chronic-relapsing form of disease. It is characterized by appearance of two peaks of clinical symptoms, but since previously we found that MT-I transcription and MT-I+II immunoreactivity in neural tissues were significantly upregulated particularly during the first attack of EAE that occurs on day 13 or 14 after the immunization with BBH+CFA (Jakovac et al., 2011; Grubic-Kezele et al., 2013) , in this study we sacrificed the rats, exhibiting stage 3 of disease (hind legs paralysis with incontinence) at the same time (Fig. 1) .
Expression profiles of OPN and MT-I+II were examined in spinal cord and in the brain and the data were compared with findings in untreated rats and in CFA-treated rats, sacrificed at the same post-immunization (p. i.) day. As shown on Fig. 1 , these control rats, in contrast to the animals treated with BBH+CFA, did not develop any clinical symptom of disease (p < 0.001).
Fig. 1
Expression of OPN during the First Relapse of EAE in Spinal Cord
Profiling of OPN mRNA and proteins by qPCR and Western blot (WB) showed that transcription of OPN gene was significantly greater in rats immunized with encephalitogen than in control rats (Fig. 2 A; p<0.05). Moreover, WB revealed that in these rats the cytoplasmic SC lysates contained more OPN fragments of small molecular length (32 kDa) than intact and CFA-treated rats (Fig. 2 B and C; p<0.05), implying that immunization had stimulated the proteolytic cleavage of OPN. Immunohistochemical data (Fig. 2 D) also showed that OPN expression in EAE rats was highly upregulated around plaques (a) and on cells surrounding blood vessels in white matter (b, e, red head arrow), in choroid plexus and subarachnoid places (c, d), as well as in numerous motor neurons in the grey matter of spinal cord (f). The absence of these changes in rats treated with CFA (Fig. 2 D g, h) confirmed that they were specific for encephalitogen. Besides, all slides used as negative controls, did not show any immunopositivity (Fig 2 D, inserts on g, h) . 
Expression of MT I+II during the First Relapse of EAE in Spinal Cord
Simultaneously, in agreement with our previous results (Jakovac et al., 2011; Grubic-Kezele et al., 2013) we found that immunization markedly elevated also the transcription of MT-I gene (Fig. 3 A) and augmented the content of MT I+II proteins in lysates of spinal cord (Fig.   3 B, C) . (p<0.001 in comparison with intact and CFA-treated rats). As shown on Fig. 3 D, MTs were upregulated diffusely in parenchyma of SC (a-f), in subependymal zones around the central canal (a, b, e), on several astrocytes (d, insert), as well as on blood vessels endothelial cells (f, head arrows). Furthermore, a very high MT immunoreactivity was found in neurons (c, f), suggesting that they were similar to those expressing OPN (Fig. 2 D f) . In contrast, the expression of MT-I+II in spinal cord of CFA treated rats was absent or very low (Fig. 3 D g, h) . Beside, in negative controls the immunopositivity was not observed (Fig. 3 D inserts on g, h). (Fig. 4 A) that within the spinal cord of EAE rats were present several CD3+ lymphocytes (a) and GFAP+ astrocytes (d). They, however, did not co-express OPN (c, f), implying that during the first attack of EAE, OPN was more expressed on other types of mononuclear cells. In the affected tissue were also present cells expressing CD44 (g), but they also did not co-express OPN (i). In contrast, a high OPN-immunoreactivity was found in almost all neurons expressing αVβ3 integrin (l, arrows). Moreover, as emphasized on Fig. 4 B (a-c, arrows), many of them contained OPN-positive granular deposits in perinuclear location, suggesting that, in these neurons OPN was directed to secretory pathway. Double staining for OPN and GM 130, a marker of Golgy, confirmed this hypothesis (Fig. 4 B e-g, arrows) , and labeling of OPN and NeuN confirmed that the accumulation of OPN-positive granular deposits occurred in mature neurons (Fig. 4 B h-j) . Noteworthy, similar findings were not found in CFA-treated rats (Fig. 4 B d) , showing that upregulation of OPN in αVβ3+ neurons was specific for the encephalitogen-induced processes. On slides used as negative controls fluorescent signals were not detected at all (not shown). expressed also a high OPN immunoreactivity (f). Moreover, the co-staining of MTs and OPN was found in soma of numerous neurons (i). In these MT+ neurons, OPN was visible in granular deposits ( Fig. 5 B b, arrow) , but also as homogenous, cytoplasmic and nuclear immunostaining (Fig. 5 A i and B a, c, head arrows), suggesting that OPN might be located also outside of the secretory vesicles. Similar changes were not observed in CFA-treated rats (Fig. 5 B d) . 
Expression and Tissue Distribution of OPN in the Brain
The data obtained by immunohistochemistry clearly showed that during first relapse of EAE the OPN expression was markedly upregulated (Fig 6, a- 
Relationship of OPN to Cells expressing α α α αVβ β β β3 in the Brain
Owing to the findings in SC (Fig. 4) , in the brain of rats treated by BBH+CFA we estimated particularly the relationship of OPN to neurons expressing αVβ3. The data (Fig. 7) clearly showed that OPN-immunoreactivity was present in cortical αVβ3+ neurons (a-c) and in several large cells located in subventricular zone (d-f). Co-staining of OPN and αVβ3 was found also on Purkinje cells in cerebellum (j-l). αVβ3 was highly upregulated also in granular cell layer (GCL) of hippocampus, but only some of these neurons expressed OPN immunoreactivity (g-i). However, as emphasized on Fig. 7 B, almost all αVβ3+ cortical cells (a-c, arrows) and NeuN+ neurons (h-j) exhibited high granular OPN immunoreactivities in structures stained with GM 130 antibodies (e-g, arrows), confirming that in these neurons OPN was confined to the secretory pathways. In control, CFA-treated rats, moderate expression of integrin αVβ3 was noticed in hippocampus (not shown), but in contrast to findings in BBH+CFA treated rats, cortical neurons of control rats did not co-express OPN ( Fig. 7 B d versus F A c) . 
Relationship of OPN to MT-I+II in the Brain
Single and double labeling of brain sections for OPN and MT in EAE rats showed that OPN and MT-I+II were co-expressed in numerous cortical neurons (Fig. 8 A a-c; B a) , in Purkinje cells in cerebellum (A j-l) and some cells located n GCL of hippocampus (A g-i, arrows). In correspnding brain areas of rats treated only with CFA the similar changes were not found (Fig. 8A , inserts on c, f, i, l). A high, encephalitogen-induced, co-staining of MTs and OPN was found also in the choroid plexus (Fig. 8 B c versus d) , as well as on large cells in subventricular zone (SVZ) (Fig.8 A d-f 
Discussion
Profound influences of OPN and ECM on basic cellular processes that affect the pathogenesis of MS and EAE have been repeatedly suggested (Steinman, 2009; Niino and Kikuchi, 2011; Brown, 2012; Plantman, 2013; Kahles et al., 2014; Rittling and Singh, 2015; Subraman et al., 2015) . However, although it is known that OPN is one of the genes most highly expressed in autoimmune demyelinating lesions (Chabas et al., 2001) , as well as that it contributes to the development of cell-mediated inflammatory responses (O'Regan et al., 2000; Cantor and Shinohara, 2009; Inoue and Shinohara, 2011; Rittling and Singh, 2015) , the complex interplay between supportive and inhibitory molecules in these events is not yet fully understood, similarly as the mechanisms that lead to the generation of functionally distinct forms of OPN during an autoimmune attack.
The data presented in this report are generally in line with the updated knowledge about the expression of OPN in EAE (Niino and Kikuchi, 2011) The data also suggest that these interactions might be linked with the proteolytic cleavage and posttranslational modification of OPN, since we found that cytoplasmic fraction of SC lysates from EAE rats contained greater amount of OPN with low molecular weight (32 kDa) than corresponding fractions obtained from CFA-treated and intact rats (Fig. 2 B, C) .
This hypothesis seems to be supported by findings that OPN fragments of 40, 32, and 25 kDa may be generated by cleavage of OPN with MMP-3 (stromelysin-1) and MMP-7 (matrilysin) (Agnihotri et al., 2001; Gao et al., 2004) and by data showing that the N-and C-terminal fragments of OPN (with approx 35 kDa and 25 kDa, respectively) may be produced by cleavage of OPN by thrombin (Morimoto et al., 2010; Boggio et al., 2016) . In our study the proteolytic cleavage of OPN should be better defined by the use of mAb specific for OPN sequences and by determination of functional activity of the generated segments, but it is noteworthy that OPN fragments generated by proteolysis may exhibit new properties and expose higher adhesive activities for integrins, owing to the exposure of RGD motif and a cryptic SVVYGLR or SLAYGLR segments on N-terminal fragment of OPN molecule (Agnihotri et al., 2001; Gao et al., 2004; Boggio et al., 2016) . In this context Boggio and co- Furthermore, for our data it may be relevant that Morisaki et al. (2016) in rodent models of amyotrophic lateral sclerosis (ALS), found that OPN in spinal motor neurons stimulated MMP-9 transcription and expression through αvβ3 integrin-mediated transduction. In this condition the activation of OPN-integrin αvβ3-MMP-9 axis has been viewed as a sign of selective motor neurons vulnerability and second-wave neurodegeneration in ALS, but the contribution of these processes to active remodeling of neurons was also emphasized (Morisaki et al., 2016) .
Our data, showing that in SC of EAE-rats are generated OPN fragments of small size ( (Andrews, 2000; Davis and Cousins, 2000; Mocchegiani et al., 2000; Lynes et al., 2006; Rink and Haase, 2007; Inoue et al., 2009; Isani and Carpene, 2014; Ling et al., 2016) . Moreover, for our data showing OPN/MTs co-expression in neurons (Figs. 5 and 8) it may be particularly relevant that MTs may prevent demyelination and axonal damage and increase oligodendrocyte precursors proliferation during EAE and preserve the mitochondrial structural and functional integrity by augmentation of mitochondrial coenzyme Q10, glutathione, ferritin, melatonin, and neuromelanin synthesis in neurons (Sharma et al., 2013) .
As shown by Ambjřrn and coworkers (2008) , the survival-promoting effects of MT and its synthetic analog EmtinB on neurons include binding of MT to surface receptors of the low-density lipoprotein receptor (LDLR) family, such as megalin and lipoprotein receptor-related protein-1, and activation of signal transduction pathways that promote neurite outgrowth and survival or abrogate the apoptosis. In this context we may speculate that binding of MT to multiligand, surface receptors might affect also the OPN-αvβ3 integrin-MMP-9 axis and other post-translational processes, such as phosphorylation, glycosylation and sulfation that determine OPN signaling and its functions in various cell types (Kazanecki et al., 2007; Kahles et al., 2014) ..This speculation, however, remains to be proved, similarly as the possibility that MT/zinc network affects the cell-autonomous immune mechanisms in neurons that trigger a pathogenic cascade after binding of endogenous molecules produced by stress (heat shock proteins, mRNA, fibrinogen, mitochondrial DNA) to TLRs in injured cells (Czirr and Wyss-Coray, 2012) . Noteworthy, TLR3, -7, -8, and -9 are located in the ER and endosomal compartments, where we found OPN-positive granular deposits (Figs 4, 7) , and their activation can lead to initiation of autophagy and induce the clearance of defective organelles or protein aggregates (Czirr and Wyss-Coray, 2012 ). Moreover, it should be taken into account that the cytosolic Zn level is regulated also by Zn transporters of the Slc39/ZIP and Slc30/ZnT families and that Zn may function as an intracellular signaling molecule or second messenger, either independently, or in a manner dependent on the transcriptional changes of Zn transporters or MTs (Fukada et al., 2011) .
Altogether, these evidence imply that the outcome of OPN/MT interaction in neurons might be the abrogation of detrimental functions of OPN or the stimulation of pro-regenerative and anti-apoptotic properties of OPN (Carecchio and Comi, 2011; Plantman, 2013) The latter, is emphasized also by findings that recombinant OPN upregulates myelination and remyelination in in vitro cellular cultures (Selvaraju et al., 2004) , by data showing that RGDcontaining peptide fragment of OPN protects dopaminergic neurons against toxic insult (Iczkiewicz et al., 2010) , as well as by findings that OPN stimulates neurite growth of hippocampal neurons (Plantman, 2012) and facilitates the regeneration of motor neurons axons (Wright et al., 2014 ).
Herein we also show that during first attack of EAE the expression of OPN and MT-I+II increases at sites of cellular invasion and T cell reactivation, such as BBB, choroid plexus and leptomeninges around the spinal cord (Figs 3. 4) , as well as that several ependymal cells and inflammatory cells around the blood vessels in demyelinating plaques co-localize OPN and MT (Fig. 8) . These data are in high agreement with evidence showing that both OPN (Shinohara et al., 2008a; Cantor and Shinohara, 2009; Morimoto et al., 2010; Inoue and Shinohara, 2011; Hellewell and Adams, 2015) and MT/Zn network have high impact on innate and adaptive immunity (Mocchegiani et al., 2000; Prasad, 2008; Fukada et al., 2011; Haase and Rink, 2014) . The mechanisms of OPN/MT interaction in our experimental model, however, remain to be elucidated, since in the development of EAE are involved various cell types and different OPN isoforms (Cantor and Shinohara, 2009 ). Thus, the plasmacytoid DC, containing i-OPN, may be more responsible for the generation of pro-inflammatory TH17 cells and the onset of EAE (Shinohara et al., 2008a) . In contrast, it is likely that s-OPN, produced by activated T-cells, contributes more to the development of relapse and progression of EAE (Hur et al., 2007) . However, as shown by Boggio et al. (2016) the OPN activity in all these steps may be dependent on thrombin-induced cleavage, since OPN effects on IL-17 and IL-6 secretion and cell migration were mainly ascribable to OPN-N, whereas those on IL-10 secretion and cell adhesion were mainly mediated by OPN-C.
Our data imply that during first attack of EAE OPN and MTs were more expressed in monocyte and microglia-like cells (Fig. 5 A f) and that OPN activities were more related to its RGD-binding domain of OPN than to OPN-C fragment, but in spite of the fact that these findings are in line with current knowledge showing that binding of RGD fragment of many ECM proteins leads to activation and conformational change of integrin receptor and activation of an "outside-in" and an "inside-out" signaling cascades (Wu and Reddy, 2012) our study requires additional phenotypic and functional analyses.
In conclusion our data show that acute phase of EAE in DA rats is followed by increased 
